| Before propensity score matching | After propensity score matching | ||||
---|---|---|---|---|---|---|
NPR on clopidogrel (n = 1360) | HPR on clopidogrel (n = 409) | P Value | NPR on clopidogrel (n = 395) | HPR on clopidogrel (n = 395) | P Value | |
Age, year | 64.6 ± 10.2 | 66.9 ± 10.2 | < 0.001 | 66.5 ± 9.8 | 66.7 ± 10.2 | 0.765 |
Male, n (%) | 1028 (75.6) | 289 (70.7) | 0.045 | 264 (66.8) | 278 (70.4) | 0.283 |
BMI, kg/mm2 | 24.6 ± 2.9 | 25.1 ± 3.6 | 0.003 | 25.3 ± 3.1 | 25.0 ± 3.1 | 0.169 |
Hypertension, n (%) | 949 (69.8) | 311 (76.0) | 0.014 | 298 (75.4) | 305 (77.2) | 0.558 |
Hyperlipidemia, n (%) | 521 (38.3) | 204 (49.9) | < 0.001 | 198 (50.1) | 200 (50.6) | 0.887 |
Diabetes, n (%) | 372 (27.4) | 127 (31.1) | 0.145 | 118 (29.9) | 125 (31.6) | 0.589 |
Current smoker, n (%) | 511 (37.6) | 132 (32.3) | 0.051 | 137 (34.7) | 131 (33.2) | 0.652 |
ACS, n (%) | 1226 (90.1) | 361 (88.3) | 0.272 | 359 (90.9) | 349 (88.4) | 0.243 |
eGFR ≥60 ml/min/1.73m2, n(%) | 1205 (88.9) | 359 (88.0) | 0.625 | 339 (86.5) | 347 (88.1) | 0.503 |
Prior stroke, n (%) | 18 (1.3) | 15 (3.7) | 0.005 | 5 (1.3) | 12 (3.0) | 0.086 |
Prior MI, n (%) | 124 (9.1) | 49 (12.0) | 0.088 | 42 (10.6) | 48 (12.2) | 0.502 |
Prior PCI, n (%) | 267 (19.6) | 96 (23.5) | 0.092 | 76 (19.2) | 96 (24.3) | 0.085 |
Prior CABG, n (%) | 12 (0.9) | 6 (1.5) | 0.397 | 3 (0.8) | 6 (1.5) | 0.505 |
LVEF, % | 59.7 ± 9.0 | 58.4 ± 8.2 | 0.488 | 58.5 ± 9.4 | 58.4 ± 8.2 | 0.952 |
Symptomatic HF, n (%) | 222 (16.5) | 79 (19.6) | 0.155 | 97 (24.6) | 79 (20.0) | 0.124 |
Treatment at discharge | ||||||
 Aspirin maintenance dose, n (%) | 1360 (100) | 408 (99.8) | 0.231 | 395 (100) | 394 (99.7) | 0.317 |
 Clopidogrel maintenance dose of 75 mg, n (%) | 1331 (97.9) | 395 (96.6) | 0.137 | 381 (96.5) | 381 (96.5) | NS |
 Clopidogrel maintenance dose of 150 mg, n (%) | 29 (2.1) | 14 (3.4) | 0.137 | 14 (3.5) | 14 (3.5) | NS |
Treatment at last follow-up visit | ||||||
 Aspirin maintenance dose, n (%) | 1292 (95) | 386 (94.4) | 0.617 | 376 (95.2) | 372 (94.2) | 0.526 |
 Clopidogrel maintenance dose, n (%) | 494 (36.3) | 140 (34.2) | 0.439 | 132 (33.4) | 127 (32.2) | 0.705 |
 Ticagrelor maintenance dose, n (%) | 11 (0.8) | 5 (1.2) | 0.388 | 6 (1.5) | 4 (1.0) | 0.524 |
Laboratory | ||||||
 Red blood cell, ×  1012/L | 4.4 ± 0.6 | 4.6 ± 6.5 | 0.314 | 4.3 ± 0.6 | 4.6 ± 6.5 | 0.596 |
 Hemoglobin, g/L | 133.7 ± 17.2 | 132.1 ± 55.3 | 0.436 | 132.0 ± 17.9 | 132.2 ± 55.8 | 0.973 |
 Platelet count, × 109/L | 190.6 ± 66.9 | 190.3 ± 51.5 | 0.937 | 186.1 ± 55.5 | 189.9 ± 51.1 | 0.431 |
 hsCRP, ug/ml | 32.1 ± 8.9 | 31.9 ± 8.8 | 0.858 | 31.8 ± 8.6 | 31.9 ± 8.9 | 0.883 |